Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on: March 14,2024

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on:March 14,2024

Permanent hair dye and straighteners may increase breast cancer risk

by National Institutes of HealthThe study found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don't use t

Updated on: May 11,2024

Permanent hair dye and straighteners may increase breast cancer risk

by National Institutes of HealthThe study found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don't use t

Updated on:May 11,2024

Immunotherapy for HPV+ head and neck cancer: Awakening the force within

by Emory UniversityCredit: Pixabay/CC0 Public DomainA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the

Updated on: April 16,2024

Immunotherapy for HPV+ head and neck cancer: Awakening the force within

by Emory UniversityCredit: Pixabay/CC0 Public DomainA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the

Updated on:April 16,2024

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Updated on: December 28,2023

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Updated on:December 28,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

Updated on: January 26,2024

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

Updated on:January 26,2024

New pancreatic cancer treatment proves effective in shrinking, clearing tumors

byUniversity of Massachusetts AmherstPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteResearchers at the University of Massachusett

Updated on: September 07,2024

New pancreatic cancer treatment proves effective in shrinking, clearing tumors

byUniversity of Massachusetts AmherstPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteResearchers at the University of Massachusett

Updated on:September 07,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on: January 12,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on:January 12,2024

Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukemia

byJosep Carreras Leukaemia Research InstitutePax5 K198 acetylation regulates gene expression. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01995-7More than 400 people, 80%

Updated on: November 10,2024

Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukemia

byJosep Carreras Leukaemia Research InstitutePax5 K198 acetylation regulates gene expression. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01995-7More than 400 people, 80%

Updated on:November 10,2024

Pediatric brain cancer is rare. A doctor explains why some kids are more vulnerable than others

by Wendy RudermanCredit: Unsplash/CC0 Public DomainThe odds that a doctor will diagnose your child with pediatric cancer are slim, and the chances of a brain cancer diagnosis are even smaller.Each yea

Updated on: January 11,2024

Pediatric brain cancer is rare. A doctor explains why some kids are more vulnerable than others

by Wendy RudermanCredit: Unsplash/CC0 Public DomainThe odds that a doctor will diagnose your child with pediatric cancer are slim, and the chances of a brain cancer diagnosis are even smaller.Each yea

Updated on:January 11,2024

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Updated on: May 27,2024

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Updated on:May 27,2024